Loading...
OTCM
TKUNF
Market cap1mUSD
Feb 23, Last price  
1.50USD
Name

Tikun Olam Cannbit Pharmaceuticals Ltd

Chart & Performance

D1W1MN
OTCM:TKUNF chart
P/E
—
P/S
0.42
EPS
—
Div Yield, %
—
Shrs. gr., 5y
18.46%
Rev. gr., 5y
-15.92%
Revenues
9m
-73.96%
002,596,00000000021,659,00037,030,00049,297,00044,228,00034,952,0009,102,000
Net income
-16m
L-60.47%
21,781,000-20,175,000-13,374,000-4,106,000-2,829,000-902,000-441,000-21,173,000-10,888,000-32,941,000-32,651,000-48,235,000-88,886,000-40,101,000-15,853,000
CFO
618k
P
-3,040,000-2,937,000-2,423,000-1,969,000-2,434,000-532,000-439,000-1,758,000-3,356,000-24,378,000-23,173,000-18,216,000-3,024,000-3,772,000617,999

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers clinical research, training, and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd was founded in 2006 and is based in Nof HaGalil, Israel.
URL
https://cannbit.com/
IPO date
Mar 01, 2000
Employees
102
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT